MR

Miroslav Rapta

TI Theravance Biopharma R&D Ip: 5 patents #2 of 51Top 4%
🗺 California: #4,328 of 67,890 inventorsTop 7%
Overall (2019): #32,244 of 560,194Top 6%
5
Patents 2019

Issued Patents 2019

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10472335 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet 2019-11-12
10426766 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound Sean Dalziel, Leticia M. Preza, Pierre-Jean Colson 2019-10-01
10392368 Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Erik Fenster, Tom M. Lam, Mandy Loo, Robert Murray McKinnell, Anthony Francesco Palermo +5 more 2019-08-27
10226454 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Lori Jean Patterson, Robert S. Chao 2019-03-12
10172834 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi 2019-01-08